Citations

Citations to this article as recorded by  

• Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM)
  Min Kyoung Jang, Yun Kyung Cho, Jung Yoon Moon, Se Hee Min, Ju Hee Hwang, Chang Hee Jung
  Primary Care Diabetes.2026; 20(1): 47.     CrossRef
• Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24‐week, randomized, open‐label, multicenter trial
  So Ra Kim, Jun Hwa Hong, Sin Gon Kim, Soo‐Kyung Kim, Hyuk‐Sang Kwon, Jun Sung Moon, Jung Hwan Park, Jae Myung Yu, Bong‐Soo Cha, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
• Glucagon-like Peptide-1 Receptor Agonists and Gastrointestinal Neoplasms
  Yu Jin Kim, Jaehyun Bae
  Journal of Digestive Cancer Research.2025; 13(2): 99.     CrossRef
• Is the next STEP on the BPROAD to intensive blood pressure lowering for all type 2 diabetic patients?: consensus statements from the Korean Society of Hypertension
  Eun Mi Lee, In-Jeong Cho, Hae Jin Kim, Dae-Hee Kim, Hae-Young Lee, Sungha Park, Sang-Hyun Ihm
  Clinical Hypertension.2025;[Epub]     CrossRef
• Lifestyle prescriptions for diabetes management in primary care: a narrative review
  Hye Jun Lee, Jung-Ha Kim
  Ewha Medical Journal.2025; 48(4): e55.     CrossRef
• Continuous Glucose Monitoring for Pancreatogenic Diabetes After Total Pancreatectomy
  Young Jae Cho, Inhyuck Lee, Yoon Soo Chae, Go‐Won Choi, Younsoo Seo, Youngmin Han, Hye‐sol Jung, Wooil Kwon, Joon Seong Park, Jin‐Young Jang
  Journal of Hepato-Biliary-Pancreatic Sciences.2025;[Epub]     CrossRef
• Real‐World Evidence of Long‐Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years
  Hwi Seung Kim, Myung Jin Kim, Hee Sung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee
  Clinical Endocrinology.2025;[Epub]     CrossRef
• Obesity Pharmacotherapy: A Practical Approach to Patient-Centered Medication Selection
  Jungha Park
  Korean Journal of Family Practice.2025; 15(4): 194.     CrossRef
• Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial
  Seung‐Hwan Lee, Kyung Ah Han, Eun‐Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, Jung‐Hwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, In‐Kyung Jeong, Sung Wan Chun, Young Min Cho
  Diabetes, Obesity and Metabolism.2025;[Epub]     CrossRef
• Genetic Variants in HTR3B Locus Influence Glycemic Control and Type 2 Diabetes Susceptibility in Koreans
  Sangwook Park
  Biomedical Science Letters.2025; 31(4): 364.     CrossRef

Citations

Citations to this article as recorded by  

• Novel metabolic syndrome subgroups and their association with cardiovascular outcomes: A data‐driven cluster analysis of the UK Biobank
  Yongin Cho, Hye‐Sun Park, Dae Hyung Lee, Young Ju Suh, Jong Ho Jhee, Jong Hyun Jhee, So Hun Kim
  Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
• Pharmacological management of diabetes in older adults
  Junghyun Noh
  Cardiovascular Prevention and Pharmacotherapy.2025; 7(1): 13.     CrossRef
• Effects of e-health literacy on health-related quality of life in young adults with type 2 diabetes: Parallel mediation of diabetes self-efficacy and self-care behaviors
  Yura Jang, Youngran Yang
  Applied Nursing Research.2025; 82: 151917.     CrossRef
• Prevalence, Incidence, and Metabolic Characteristics of Young Adults with Type 2 Diabetes Mellitus in South Korea (2010–2020)
  Ji Yoon Kim, Jiyoon Lee, Joon Ho Moon, Se Eun Park, Seung-Hyun Ko, Sung Hee Choi, Nam Hoon Kim
  Diabetes & Metabolism Journal.2025; 49(2): 172.     CrossRef
• Workplace‐based continuous glucose monitoring with structured education for pre‐diabetes and type 2 diabetes: A prospective community cohort study
  Ji‐Hee Ko, Sun‐Joon Moon, Ramzi A. Ajjan, Mi Yeon Lee, Hae‐Jeong Lee, Boram Choi, JiYeon Park, Seung‐Eun Lee, Jae‐Hyeon Kang, Cheol‐Young Park
  Diabetes, Obesity and Metabolism.2025; 27(6): 2996.     CrossRef
• Multidisciplinary Care Model as a Center of Excellence for Fabry Disease: A Practical Guide to Diagnosis and Management by Clinical Specialty in South Korea
  Soo Yong Lee, Il Young Kim, Sung-Ho Ahn, Su Jin Kim, Hyun-Min Lee, Ji Eun Lee, Gyeong-Jo Byeon, Hyun-Chang Ko, Hyun Jung Lee, Songhwa Choi, Chong Kun Cheon
  Journal of Clinical Medicine.2025; 14(13): 4400.     CrossRef
• The Effect of Frailty on Body Composition and Its Impact on the Use of SGLT-2 Inhibitors and GLP-1RA in Older Persons with Diabetes
  Alan Sinclair, Izel Siqueira, Ahmed Abdelhafiz
  Metabolites.2025; 15(6): 381.     CrossRef
• Feasibility of a Structured Calorie-Restricted Dietary Intervention in Korean Adults with Early Type 2 Diabetes and Obesity: A Pilot Study
  Su-Jeong Park, Mee Kyung Kim, Jinyoung Kim, Ji-Yeon Choi, YoonJu Song, Hyuk-Sang Kwon
  Nutrients.2025; 17(9): 1530.     CrossRef
• Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study
  Kyoung Hwa Ha, Minae Park, Yujin Lee, Dae Jung Kim, Seung Jin Han
  Diabetes & Metabolism.2025; 51(5): 101668.     CrossRef
• How Do We Diagnose Diabetes in Primary Care?
  Hyeong Jin Kim
  The Journal of Korean Diabetes.2025; 26(1): 10.     CrossRef
• Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: A cross-sectional study
  Ji Yoon Kim, Seohyun Kim, Sang Ho Park, Jin A Lee, So Hyun Cho, Rosa Oh, Myunghwa Jang, You-Bin Lee, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
  Diabetes Research and Clinical Practice.2025; 226: 112325.     CrossRef
• Diabetes medication management recommendations for older adults: A systematic review of the Western Pacific region
  Darshna Goordeen, J Simon Bell, Youmna Elsedfy, Soroush Fariman, Shota Hamada, Yukari Hattori, Kate Wang, Majd Abu Al Shieh, Michael Nunan, Joshua D Niznik, Emily Reeve
  Geriatrics & Gerontology International.2025; 25(6): 717.     CrossRef
• Medical Nutrition Therapy as a Hospital-Based Lifestyle Modification in the Korean Diabetes Prevention Study
  Ji Hye Choi, Jung-Hwa Lee, Suk Chon
  The Journal of Korean Diabetes.2025; 26(1): 39.     CrossRef
• Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease
  Eugene Han, Sin Yung Woo, Justin Y. Jeon, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee, Yong-ho Lee
  Diabetes Research and Clinical Practice.2025; 224: 112209.     CrossRef
• Optimal Management of Diabetic Kidney Disease
  Jae-Han Jeon
  The Journal of Korean Diabetes.2025; 26(1): 1.     CrossRef
• Clinical Characteristics and Epidemiology of Cardiovascular Autonomic Neuropathy in Peoples With Long-Standing Diabetes
  Sook Jung Lee, Chong Hwa Kim, Su Jin Jeong, Jae-Seung Yun, Jong Chul Won, Jae Hyuk Lee, Ie Byung Park, Chang Won Lee, Hyuk-Sang Kwon, Tae Sun Park
  Journal of Korean Medical Science.2025;[Epub]     CrossRef
• Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
  Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyungdo Han, Mee Kyoung Kim
  Journal of Lipid and Atherosclerosis.2025; 14(2): 190.     CrossRef
• Recovery time of diabetic ketoacidosis in Africa: Systematic review and meta-analysis
  Tadios Lidetu, Simon Birhanu, Addisu Simachew Asgai, Tsegaamlak Kumelachew Derse, Yideg Abinew, Moges Tadesse, Desalegn Mitiku, Jemberu Chane, Banchamilak Adane, Tadele Kassahun Wudu, Betelhem Mekonnen, Desiyalew Habtamu Tamiru
  Metabolism Open.2025; 26: 100370.     CrossRef
• The utility of common predictive models for detecting undiagnosed diabetes and prediabetes defined by HbA1c in a Chinese population
  Shuqi Wang, Benjamin H.K. Yip, Paul K.M. Poon, Billy C.F. Chiu, Samuel Y.S. Wong, Juliana C.N. Chan, Eric K.P. Lee
  Diabetes Research and Clinical Practice.2025; 226: 112344.     CrossRef
• Advances in Continuous Glucose Monitoring: Clinical Applications
  So Yoon Kwon, Jun Sung Moon
  Endocrinology and Metabolism.2025; 40(2): 161.     CrossRef
• Differences between Type 2 Diabetes Mellitus and Obesity Management: Medical, Social, and Public Health Perspectives
  Soo Lim, Ga Eun Nam, Arya M. Sharma
  Diabetes & Metabolism Journal.2025; 49(4): 565.     CrossRef
• De-escalation, palliation and end of life care in frail older people with diabetes-a critical review
  I. Siqueira, J. Jenkinson, P. Briggs, H. Picker, X. Chen, A. H. Abdelhafiz
  Expert Review of Endocrinology & Metabolism.2025; 20(6): 593.     CrossRef
• Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality
  Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
  Cardiovascular Diabetology.2025;[Epub]     CrossRef
• Associations between Diabetes, Diabetes Duration, and Psychiatric Difficulties: A Nationwide Cross-sectional Study
  Young-Chan Kim, Kyungdo Han, Suhyung Kim, Yoo Hyun Um, Tae-Won Kim, Ho Jun Seo, Seung-Chul Hong, Jong-Hyun Jeong
  Clinical Psychopharmacology and Neuroscience.2025; 23(3): 476.     CrossRef
• Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study
  Ji Yoon Kim, Nam Hoon Kim, Jiyoon Lee, Dong-Hoon Kim, Sin Gon Kim
  European Heart Journal - Cardiovascular Pharmacotherapy.2025; 11(7): 620.     CrossRef
• Effects of Pilates exercise on glycated hemoglobin and fasting blood sugar in type 2 diabetes: a systematic review and meta-analysis
  Se-Na Yu, Hee-Jin Moon, Myung-Haeng Hur
  Journal of Korean Biological Nursing Science.2025; 27(3): 317.     CrossRef
• Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3
  Byung Wan Lee, Chang Beom Lee, Soo Lim, Sin Gon Kim, Nan Hee Kim, Jong Chul Won, Woo Je Lee, Min Ju Kang, Ju Young Yuh, Li Ying Du, Hyojin Lim, Kyu Jeung Ahn
  Diabetes, Obesity and Metabolism.2025; 27(12): 7110.     CrossRef
• Insulin resistance and the risk of incident depression: the role of age, glycemic status, and adiposity in a prospective cohort study
  Dae Jong Oh, Chaiho Jeong, Junhyung Kim, Eun Soo Kim, Kang-Seob Oh, Young Chul Shin, Dong-Won Shin, Sang-Won Jeon, Sung Joon Cho
  The Lancet Regional Health - Western Pacific.2025; 62: 101672.     CrossRef
• Cardiometabolic and renal benefits of sodium–glucose cotransporter 2 inhibitors
  Yong-ho Lee, Soo Lim, Melanie J. Davies
  Nature Reviews Endocrinology.2025; 21(12): 783.     CrossRef
• Physical activity for prevention of cardiovascular disease: consensus statement of Korean Society of Cardio-cerebrovascular Disease Prevention
  Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee
  The Korean Journal of Internal Medicine.2025; 40(5): 696.     CrossRef
• Nutriomics and artificial intelligence nutrition obesity cohort (NAINOC): a design paper for a prospective cohort for nutrition and obesity research
  Minyoung Lee, Sungha Park, Soo-Hyun Park, Ho-Young Park, Yu Ra Lee, Min-Sun Kim, Miso Nam, Jangho Lee, Hyein Seo, Yong-ho Lee, Chan Joo Lee, Jae-Ho Park, Hye Hyun Yoo, Hyun-Jin Kim, Kyong-Oh Shin, Yoshikazu Uchida, Kyungho Park
  Clinical Hypertension.2025;[Epub]     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes: Pharmacological Treatment of Type 2 Diabetes
  Jong Han Choi
  The Journal of Korean Diabetes.2025; 26(3): 158.     CrossRef
• Trends and differences in cardiovascular disease and alzheimer's disease-related mortality among older adults in the United States, 1999 to 2023: A CDC WONDER database analysis
  Jianren Wen, Jingxuan Hu, Guohui Zou
  American Heart Journal Plus: Cardiology Research and Practice.2025; 59: 100618.     CrossRef
• Association between alpha-lipoic acid use and macrovascular complications in patients with diabetic neuropathy
  Yongin Cho, Hye-Sun Park, Hye Sun Lee, Hyejin Yang, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, So Hun Kim
  Endocrine.2025; 90(3): 1233.     CrossRef
• The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes
  Jaehyun Bae, Minyoung Lee, Yong-ho Lee, Sang-Guk Lee, Byung-Wan Lee
  International Journal of Molecular Sciences.2025; 26(17): 8566.     CrossRef
• The effect of dioxin exposure on diabetes and potential dietary modification in the Korean population
  Youngmin Han, Keum Ji Jung, Young Wook Lim, Yong Jin Lee, Youn Seok Kang, Sun Ha Jee
  Endocrine.2025; 90(3): 1275.     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes: Cardiovascular Risk Management
  Hae Jin Kim
  The Journal of Korean Diabetes.2025; 26(3): 164.     CrossRef
• Bone Health in Type 1 and Type 2 Diabetes: Pathophysiological Mechanisms, Clinical Implications, and Management Strategies
  Hermine Carine Pouabe Epse Bodah, Suraiya Rahman Shifa, Sara Saleh, Tuba Abeer Hashmi, Tuleen Al Shawa, Badreshiya Kajal Akshaykumar, Nabeel Sufwan, Rajvinder Kaur, Andrii Shevchuk, Usman Ul Haq, Manju Rai
  SN Comprehensive Clinical Medicine.2025;[Epub]     CrossRef
• Dietary Interventions for Adults with Type 1 Diabetes: Clinical Outcomes, Guideline Alignment, and Research Gaps—A Scoping Review
  Beata Małgorzata Sperkowska, Agnieszka Chrustek, Anna Gryn-Rynko, Anna Proszowska
  Nutrients.2025; 17(21): 3349.     CrossRef
• Managing hypertension, diabetes, and dyslipidemia in frail older adults
  Jung-Yeon Choi, Cheol-Ho Kim, Kwang-il Kim
  Cardiovascular Prevention and Pharmacotherapy.2025; 7(4): 135.     CrossRef
• Physical activity for prevention of cardiovascular disease: a consensus statement of the Korean Society of Cardio-cerebrovascular Disease Prevention
  Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee
  Cardiovascular Prevention and Pharmacotherapy.2025; 7(4): 120.     CrossRef
• Current Status of Delay in Injectable Therapy among Type 2 Diabetes Mellitus Patients in South Korea: Multicenter Retrospective Study (2015–2021)
  Jong Han Choi, Min Kyong Moon, Hae Jin Kim, Kyung Ae Lee, Hyun Jin Kim, Jung Hae Ko, Jae-Seung Yun, Seung-Hyun Ko, Suk Chon, Nam Hoon Kim
  Endocrinology and Metabolism.2025; 40(5): 727.     CrossRef
• Impact of national reimbursement policy supporting test strips on glycemic control in people with insulin-treated diabetes: retrospective cohort study
  Seohyun Kim, Mira Kang, Dohyun Park, Gyuri Kim, Jae Hyeon Kim
  BMC Public Health.2025;[Epub]     CrossRef
• Beta-Cell Function, Insulin Sensitivity, and Metabolic Characteristics in Young-Onset Type 2 Diabetes Mellitus: Findings from Anam Diabetes Observational Study
  Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2025; 49(6): 1287.     CrossRef
• Efficacy and safety of pioglitazone versus dapagliflozin as an add-on to metformin and alogliptin combination therapy: the EPIDOTE study
  Kyuho Kim, Seung-Hyun Ko, Jae-Seung Yun, Kwan-Woo Lee, Eun Sook Kim, In-Kyung Jeong, Jae Hyeon Kim, Sang Yong Kim, Kyu Chang Won, Mikyung Kim, Bong-Soo Cha, Sungrae Kim, Sung Hee Choi, Eun-Jung Rhee, Sin Gon Kim, Bo Hyun Kim, Kang Seo Park, Young-Cheol Ju
  Scientific Reports.2025;[Epub]     CrossRef
• Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial Protocol
  Ji Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, Chang Hee Jung, Eun Seok Kang, Jun Sung Moon, Sun Joon Moon, So Yoon Kwon, Jee Hee Yoo, Younghoon Kim, Tae-min Lee, Chung-il Yang, Jae Hyeon Kim, Sang-Man Jin
  Endocrinology and Metabolism.2025;[Epub]     CrossRef
• A novel clinical biomarker-based Physiology Healthy Aging Index and risk of all-cause and cause-specific mortality: A 20-year prospective cohort study
  Jieun Lyu, Ji-Yun Hwang, Joong-Yeon Lim, Yoon Jung Park
  GeroScience.2025;[Epub]     CrossRef
• Clinical Considerations in Managing Obesity and Obesity-Related Comorbidities
  Hyojin Park, Sun Hyun Kim
  Korean Journal of Family Practice.2025; 15(4): 186.     CrossRef
• Review for Chinese Medicine-Specific Health Management in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus
  Rui Yao, Cuixia Lin, Shuang Lin, Yanhui Yang, Jie Zhu, Mingqian Jiang, Ran Yang
  Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4815.     CrossRef
• Risk factors for hypoglycaemia in adults with type 1 diabetes: a systematic review and meta-analysis
  Qiang Zhang, Haojie Zhou, Ruonan Lin, Liping Hu, Xiaoli Zhu
  BMC Endocrine Disorders.2025;[Epub]     CrossRef
• Adherence to the nutritional recommendations according to diabetes status in Korean adults: a cross-sectional study
  Jong Han Choi, Chen Lulu, Seon-Joo Park, Hae-Jeung Lee
  BMC Public Health.2024;[Epub]     CrossRef
• 당뇨병 치료의 진화: 관해를 향해가는 혁신적 약물치료와 첨단 관리기기의 결합
  종한 최, 민경 문
  Public Health Weekly Report.2024; 17(44): 1905.     CrossRef
• The Impact of the Dietary Inflammatory Index, Fasting Blood Glucose, and Smoking Status on the Incidence and Survival of Pancreatic Cancer: A Retrospective Case–Control Study and a Prospective Study
  Ga Hyun Lee, Yeon Hee Kim, Sang Myung Woo, Woo Jin Lee, Sung-Sik Han, Sang-Jae Park, Sherry Price, Penias Tembo, James R. Hébert, Mi Kyung Kim
  Nutrients.2024; 16(22): 3941.     CrossRef
• Enhancing Large Language Model Reliability: Minimizing Hallucinations with Dual Retrieval-Augmented Generation Based on the Latest Diabetes Guidelines
  Jaedong Lee, Hyosoung Cha, Yul Hwangbo, Wonjoong Cheon
  Journal of Personalized Medicine.2024; 14(12): 1131.     CrossRef
• High-Intensity Interval Training and Diabetes
  Yunjung Cho, Eun Sook Kim
  The Journal of Korean Diabetes.2024; 25(4): 224.     CrossRef
• SIGNIFICANCE OF URINARY AMINOPEPTIDASE N AND DIPEPTIDYL PEPTIDASE IV IN EARLY DIAGNOSIS OF KIDNEY DAMAGE IN CHILDREN WITH TYPE 1 DIABETES MELLITUS IN NORTH-EASTERN REGION OF UKRAINE
  Iryna Vikhrova, Andrii Loboda, Igor Zmyslia
  Eastern Ukrainian Medical Journal.2024; 12(4): 808.     CrossRef

Citations

Citations to this article as recorded by  

• Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24‐week, randomized, open‐label, multicenter trial
  So Ra Kim, Jun Hwa Hong, Sin Gon Kim, Soo‐Kyung Kim, Hyuk‐Sang Kwon, Jun Sung Moon, Jung Hwan Park, Jae Myung Yu, Bong‐Soo Cha, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2026;[Epub]     CrossRef
• Empagliflozin-based quadruple oral therapy for type 2 diabetes: a prospective cohort study
  Fatemeh Moosaie, Shiva Abedinzadeh, Soghra Rabizadeh, Kimia Daneshvar, Mohammadamin Noorafrooz, Fatemeh Alsadat Mojtahedi, Niloofar Deravi, Seyede Marzie Fatemi Abhari, Akam Ramezani, Alipasha Meysamie, Marzieh Hajibabaei, Sahar Karimpour Reyhan, Mahsa Ab
  Scientific Reports.2025;[Epub]     CrossRef
• Estimating Type 2 Diabetes Prevalence: A Model of Drug Consumption Data
  Rita Oliveira, Matilde Monteiro-Soares, José Pedro Guerreiro, Rúben Pereira, António Teixeira-Rodrigues
  Pharmacy.2024; 12(1): 18.     CrossRef
• Disease burden and symptom management in type 2 diabetic patients: A phenomenological study
  Sevgi Demir Çam, Sevda Uzun
  Public Health Nursing.2024; 41(6): 1291.     CrossRef
• Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study
  Nadia Gul, Inayat Ur Rehman, Yasar shah, Arbab Muhammad Ali, Zahid Ali, Omer Shehzad, Khang Wen Goh, Long Chiau Ming, Amal K. Suleiman, Nimesh Lageju
  PLOS ONE.2024; 19(11): e0311435.     CrossRef
• Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
  Kyung-Soo Kim, Kyung Ah Han, Tae Nyun Kim, Cheol-Young Park, Jung Hwan Park, Sang Yong Kim, Yong Hyun Kim, Kee Ho Song, Eun Seok Kang, Chul Sik Kim, Gwanpyo Koh, Jun Goo Kang, Mi Kyung Kim, Ji Min Han, Nan Hee Kim, Ji Oh Mok, Jae Hyuk Lee, Soo Lim, Sang S
  Diabetes & Metabolism.2023; 49(4): 101440.     CrossRef
• Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double‐blind, and placebo‐controlled study
  Minyoung Lee, Woo‐je Lee, Jae Hyeon Kim, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2022; 24(6): 1105.     CrossRef
• A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
  Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
  Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef
• Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial
  Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Yong‐Ho Lee, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2021; 23(2): 609.     CrossRef